GSA Capital Partners »

Cerevel Therapeutics Hldng I shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $577k 14k 42.40
2021-09-30 $765k 26k 29.49

More positions owned by GSA Capital Partners

Amazon (AMZN)
CRH Ord (CRH)
Remitly Global (RELY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Aon Shs Cl A (AON)
Magnite Ord (MGNI)
Zillow Group Cl A (ZG)
UnitedHealth (UNH)
Sprott Fds Tr Uranium Miners E (URNM)
Vanguard World Fds Health Car Etf (VHT)
Sba Communications Corp Cl A (SBAC)
Calavo Growers (CVGW)
Appfolio Com Cl A (APPF)
Star Bulk Carriers Corp. Shs Par (SBLK)
Bwx Technologies (BWXT)

View all positions for GSA Capital Partners

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I